
Lexicon Pharmaceuticals Inc
NASDAQ:LXRX

Intrinsic Value
The intrinsic value of one
LXRX
stock under the Base Case scenario is
0.79
USD.
Compared to the current market price of 1.21 USD,
Lexicon Pharmaceuticals Inc
is
Overvalued by 35%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Lexicon Pharmaceuticals Inc
Loading...
Fundamental Analysis


Revenue & Expenses Breakdown
Lexicon Pharmaceuticals Inc
Balance Sheet Decomposition
Lexicon Pharmaceuticals Inc
Current Assets | 245.8m |
Cash & Short-Term Investments | 194.8m |
Receivables | 47.4m |
Other Current Assets | 3.5m |
Non-Current Assets | 51.9m |
PP&E | 7m |
Intangibles | 44.5m |
Other Non-Current Assets | 368k |
Free Cash Flow Analysis
Lexicon Pharmaceuticals Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Lexicon Pharmaceuticals Inc
Revenue
|
31.2m
USD
|
Cost of Revenue
|
-615k
USD
|
Gross Profit
|
30.6m
USD
|
Operating Expenses
|
-208.1m
USD
|
Operating Income
|
-177.5m
USD
|
Other Expenses
|
162k
USD
|
Net Income
|
-177.3m
USD
|
LXRX Profitability Score
Profitability Due Diligence
Lexicon Pharmaceuticals Inc's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

Score
Lexicon Pharmaceuticals Inc's profitability score is 20/100. The higher the profitability score, the more profitable the company is.
LXRX Solvency Score
Solvency Due Diligence
Lexicon Pharmaceuticals Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Score
Lexicon Pharmaceuticals Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
LXRX Price Targets Summary
Lexicon Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
LXRX
is 2.63 USD
with a low forecast of 0.71 USD and a high forecast of 6.3 USD.
Dividends
Current shareholder yield for LXRX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
LXRX
stock under the Base Case scenario is
0.79
USD.
Compared to the current market price of 1.21 USD,
Lexicon Pharmaceuticals Inc
is
Overvalued by 35%.